Ph.D. Oliver Schacht - 02 Mar 2023 Form 4 Insider Report for OPGEN INC (OPGN)

Role
Chief Executive Officer, Director
Signature
/s/ Oliver Schacht, Ph.D.
Issuer symbol
OPGN
Transactions as of
02 Mar 2023
Net transactions value
$0
Form type
4
Filing time
06 Mar 2023, 16:15:18 UTC
Previous filing
04 Apr 2022
Next filing
31 Mar 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OPGN Common Stock Options Exercise $0 +1,875 +55% $0.000000 5,312 02 Mar 2023 Direct
transaction OPGN Common Stock Options Exercise $0 +1,938 +36% $0.000000 7,250 03 Mar 2023 Direct
holding OPGN Common Stock 250 02 Mar 2023 As custodian for minor son

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction OPGN Restricted Stock Units Options Exercise $0 -1,938 -50% $0.000000 1,938 03 Mar 2023 Common Stock 1,938 Direct F1, F2
transaction OPGN Restricted Stock Units Options Exercise $0 -1,875 -50% $0.000000 1,875 02 Mar 2023 Common Stock 1,875 Direct F3, F4
transaction OPGN Restricted Stock Units Award $0 +10,000 $0.000000 10,000 02 Mar 2023 Common Stock 10,000 Direct F5, F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents vesting of restricted stock units ("RSUs") granted in March 2021 that convert into common stock on a one-for-one basis as adjusted for a 1-for-20 reverse stock split.
F2 On March 3, 2021, the Reporting Person was granted 3,875 RSUs (as adjusted for a 1-for-20 reverse stock split). The RSUs were granted subject to forfeiture, which forfeiture restrictions will lapse as to one half of the award on the first and second anniversaries of the date of grant, subject to acceleration as set forth in the Reporting Person's employment agreement with the Registrant.
F3 Represents vesting of restricted stock units ("RSUs") granted in March 2022 that convert into common stock on a one-for-one basis as adjusted for a 1-for-20 reverse stock split.
F4 On March 2, 2022, the Reporting Person was granted 3,750 RSUs (as adjusted for a 1-for-20 reverse stock split). The RSUs were granted subject to forfeiture, which forfeiture restrictions will lapse as to one half of the award on the first and second anniversaries of the date of grant, subject to acceleration as set forth in the Reporting Person's employment agreement with the Registrant.
F5 Each RSU represents a contingent right to receive one share of OpGen common stock.
F6 RSUs granted on March 2, 2023 pursuant to the OpGen 2015 Equity Incentive Plan. The RSUs have a two year vesting schedule, vesting annually in equal installments on the anniversary of March 2, 2023.

Remarks:

All share numbers reported on this Form 4 reflect a 1-for-20 reverse stock split of OpGen's common stock effected on January 5, 2023.